ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 10526 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 10526; 2) Community: the network communities that were significantly associated with the response to NSC 10526; 3) Molecule: the relationships between components within communities and NSC 10526; 4) MDR: the compounds that were significantly associated with the NSC 10526.

NSC Compound Enrichment Correlation
NSC 718812 Null 0.0284045326811616 0.32601718
NSC 722779 dabequine 0.0284045326811616 0.14900339
NSC 724771 Null 0.0284045326811616 0.31581934
NSC 726718 3-(Benzothiazol-6-ylamino)-7-chloro-8-methyl-1,1,-dioxo-4H-1 ,5,2-benzodithiazepin-4-ylideneacetic acid 0.0284045326811616 0.20719273
NSC 726902 Null 0.0284045326811616 0.21483693
NSC 727985 NSC 708781 incorporated in micelles, 0.55% (w/w) of drug 0.0284045326811616 0.23535303
NSC 728319 6-(3-Homopiperazinyl1-1-propyl)-5,6-dihydro-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Dihydrochloride 0.0284045326811616 0.2499863
NSC 728512 1-Allyl-2-[4-chloro-5-(4-chlorophenylcarbamoyl)-2-methylthio benzenesulfonyl]-3-(5-nitro-2-furfulienimino)guanidine 0.0284045326811616 0.39034874
NSC 730294 Null 0.0284045326811616 0.23830991
NSC 730460 16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-3b-py rrolidino-5-androsten-17b-YL acetate 0.0284045326811616 0.3539026
Total:115  Current:71    [First] [Prev] [Next] [Last]